Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair changes during Mounjaro treatment are one of the most common things patients bring up — and the answer isn't quite what most people expect. Tirzepatide itself does not stimulate hair growth. What patients notice is a predictable biological response to rapid weight loss, not a direct drug effect. Understanding the difference shapes how you manage it. These are prescription-only medicines; everything here applies within the context of clinical supervision.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks: "Is Mounjaro making my hair fall out, or making it grow differently?" The honest answer is that tirzepatide does not act directly on hair follicles. What it does, very effectively, is reduce appetite and accelerate weight loss, and it is that weight loss, particularly when it happens quickly, that triggers a well-documented hair response.
The mechanism is telogen effluvium. Hair follicles cycle through active growth (anagen) and a resting phase (telogen) continuously. When the body experiences significant physiological stress (which rapid calorie reduction counts as) a larger-than-usual proportion of follicles shift prematurely into the resting phase. Six to twelve weeks later, those resting hairs shed together. The timing means people often notice increased shedding two to three months into treatment, once weight loss is well underway. It feels sudden because the shedding phase arrives as a wave rather than a trickle. You can read more about the hair-loss side of this on our do you lose hair on Mounjaro page.
Tirzepatide hair growth queries sometimes reflect the opposite hope: that the medicine might improve hair because metabolic improvements often benefit skin and hair health over the long term. That is plausible once weight stabilises and nutritional status improves, but there is no clinical evidence that Mounjaro has any direct hair-stimulating action. The NHS notes that hair loss is a recognised, usually temporary side effect of significant weight change rather than a specific drug toxicity. [Source: NHS guidance on tirzepatide]
Not everyone on Mounjaro experiences noticeable shedding, and the difference frequently comes down to diet quality during weight loss. When appetite drops sharply, total calorie intake falls, but so does protein intake unless it is actively prioritised. Hair is almost entirely keratin, a protein, so a sustained shortfall in dietary protein is one of the most reliable ways to worsen telogen effluvium.
Practical priorities: aim to eat protein at every meal even when appetite is reduced, because small portions can still deliver adequate protein if the foods are protein-dense (eggs, fish, lean meat, dairy, legumes). Micronutrient gaps matter too, low ferritin (stored iron), low zinc, and low vitamin D are each independently linked to excess shedding, and all three can drop during rapid weight loss. A blood test through your GP or prescriber can identify these gaps before they become a problem.
Staying hydrated supports hair shaft quality, and if dryness or texture changes are also a concern, our Mounjaro dry hair page covers that side of things in more detail. Strength-based activity helps preserve lean muscle mass during weight loss, which reduces the overall physiological stress signal to follicles, another reason exercise is recommended alongside treatment. Personal dietary targets during treatment are always best set with your prescriber or a registered dietitian rather than from general guidance.
For most people, the shedding from telogen effluvium is self-limiting. Once the physiological stressor (in this case rapid early weight loss) begins to moderate, the follicles cycle back into the anagen phase. Visible regrowth typically appears within three to six months of the shedding peak, though the exact timeline varies by individual. The new hair may initially appear finer; density usually recovers over the following months.
If regrowth has not started within six months, or if shedding is severe rather than gradual, it is worth asking your prescriber to rule out other causes. Thyroid dysfunction, in particular, can be exacerbated by significant weight change and produces its own hair-thinning pattern that does not resolve on the same timeline. Iron deficiency anaemia is another common culprit that is straightforward to identify and treat.
For a closer look at the evidence on whether and how regrowth happens after stopping or continuing Mounjaro, the does hair grow back after Mounjaro page covers that question directly. The will my hair grow back after Mounjaro page addresses what patients want to know when they are actively worried about permanence.
Most hair changes during Mounjaro treatment are manageable and transient. There are situations, though, where prompt discussion with a prescriber matters more. Significant shedding that begins in the first few weeks of treatment (before meaningful weight loss has occurred) is less typical of telogen effluvium and warrants investigation. Patchy rather than diffuse shedding suggests a different cause entirely. And any hair change that continues or worsens after weight has stabilised needs clinical review, not watchful waiting.
The MHRA encourages patients to report unexpected side effects (including hair changes) via the Yellow Card scheme, which helps build the post-marketing safety picture for newer medicines like tirzepatide (it carries a Black Triangle ▼ status reflecting its ongoing monitoring). You can also find general information on what the Mounjaro treatment journey involves at our Mounjaro overview page, or explore the broader Mounjaro and hair changes topic if you want the full picture.
If you have questions about starting treatment, or want a prescriber to review your current situation, our free consultation is the place to start. A real clinician reviews your answers the same day, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.